基金-话题@MedSci

#基金#

923篇内容 | 15123人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2224916, encodeId=bb8222249161d, content=<a href='/topic/show?id=c030421865b' target=_blank style='color:#2F92EE;'>#基金#</a> <a href='/topic/show?id=73c423e2572' target=_blank style='color:#2F92EE;'>#乳腺癌#</a>, objectTitle=乳腺癌，美国在研的760项基金项目简述（2024）, objectType=article, longId=842510, objectId=982084251074, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240714/1720951245077_5579292.jpg, objectUrl=/article/show_article.do?id=982084251074, replyNumber=0, likeNumber=73, createdTime=2024-09-09, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=982084251074, moduleTitle=乳腺癌，美国在研的760项基金项目简述（2024）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=982084251074)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2175403, encodeId=777d21e5403a3, content=<a href='/topic/show?id=c030421865b' target=_blank style='color:#2F92EE;'>#基金#</a> 平台太高，水太深, objectTitle=基金, objectType=topic, longId=42186, objectId=null, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=null, replyNumber=0, likeNumber=96, createdTime=2023-12-17, rootId=0, userName=ms1000000687639315, userId=9d545434460, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=江苏省, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2173280, encodeId=80d821e3280f7, content=<a href='/topic/show?id=c030421865b' target=_blank style='color:#2F92EE;'>#基金#</a> 中科院植物园全国招募药用植物学中药学相关专业联合培养研究生（长期有效），联合培养单位位于世界风景名胜区庐山，目前一园四区格局，分别在南昌、九江、庐山风景区、庐山市设实验室和办公区，并在江西各地设有多个研究基地。因中草药研究项目需要，现长期向全国高校招聘以下专业联合培养硕士、博士研究生（中药学及相关专业，植物学、生物技术、农学、生物信息学、生态学等）。导师将协助与所在高校相关合作手续，研究开展期间发放有竞争力的生活补助并提供食宿。有意者可联系 chengcs@lsbg.cn, objectTitle=基金, objectType=topic, longId=42186, objectId=null, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=null, replyNumber=0, likeNumber=82, createdTime=2023-12-06, rootId=0, userName=ms2000000396662378, userId=dd648325842, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=澳门, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=1), GetTopicListResponse(id=2144447, encodeId=a572214444e34, content=<a href='/topic/show?id=c030421865b' target=_blank style='color:#2F92EE;'>#基金#</a>学习了, objectTitle=基金, objectType=topic, longId=42186, objectId=null, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=null, replyNumber=0, likeNumber=105, createdTime=2023-06-24, rootId=0, userName=ms5000000069254713, userId=c5a25410119, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2142240, encodeId=cf7c214224055, content=<a href='/topic/show?id=c030421865b' target=_blank style='color:#2F92EE;'>#基金#</a>基金不是一个人想弄就弄得, objectTitle=基金, objectType=topic, longId=42186, objectId=null, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=null, replyNumber=0, likeNumber=75, createdTime=2023-06-11, rootId=0, userName=146480bem82暂无昵称, userId=05155126416, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2142284, encodeId=8d4e214228484, content=<a href='/topic/show?id=c030421865b' target=_blank style='color:#2F92EE;'>#基金#</a>学习打卡谢谢分享谢谢老师分享, objectTitle=基金, objectType=topic, longId=42186, objectId=null, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=null, replyNumber=0, likeNumber=131, createdTime=2023-06-11, rootId=0, userName=雪莲药师, userId=3d246474217, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2142282, encodeId=8d2a214228247, content=<a href='/topic/show?id=c030421865b' target=_blank style='color:#2F92EE;'>#基金#</a>学习打卡谢谢分享谢谢老师分享, objectTitle=基金, objectType=topic, longId=42186, objectId=null, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=null, replyNumber=0, likeNumber=93, createdTime=2023-06-11, rootId=0, userName=移动雪莲, userId=62926421654, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2142313, encodeId=3891214231315, content=<a href='/topic/show?id=c030421865b' target=_blank style='color:#2F92EE;'>#基金#</a>学习打卡, objectTitle=基金, objectType=topic, longId=42186, objectId=null, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=null, replyNumber=0, likeNumber=0, createdTime=2023-06-12, rootId=0, userName=ms300, userId=e2716443372, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2142118, encodeId=9d99214211884, content=<a href='/topic/show?id=c030421865b' target=_blank style='color:#2F92EE;'>#基金#</a>坚持学习谢谢分享谢谢, objectTitle=基金, objectType=topic, longId=42186, objectId=null, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=null, replyNumber=0, likeNumber=140, createdTime=2023-06-10, rootId=0, userName=移动雪莲, userId=62926421654, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2141955, encodeId=7a57214195527, content=<a href='/topic/show?id=c030421865b' target=_blank style='color:#2F92EE;'>#基金#</a>非常好谢谢分享学习了谢谢, objectTitle=基金, objectType=topic, longId=42186, objectId=null, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=null, replyNumber=0, likeNumber=103, createdTime=2023-06-09, rootId=0, userName=移动雪莲, userId=62926421654, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2141775, encodeId=ebe32141e754a, content=<a href='/topic/show?id=c030421865b' target=_blank style='color:#2F92EE;'>#基金#</a>有没有科研基金基层啊, objectTitle=基金, objectType=topic, longId=42186, objectId=null, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=null, replyNumber=0, likeNumber=78, createdTime=2023-06-08, rootId=0, userName=齐广西, userId=3d162090300, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2139049, encodeId=c4602139049aa, content=<a href='/topic/show?id=c030421865b' target=_blank style='color:#2F92EE;'>#基金#</a>坚持学习谢谢分享谢谢, objectTitle=基金, objectType=topic, longId=42186, objectId=null, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=null, replyNumber=0, likeNumber=98, createdTime=2023-05-25, rootId=0, userName=移动雪莲, userId=62926421654, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2139046, encodeId=fac5213904652, content=<a href='/topic/show?id=c030421865b' target=_blank style='color:#2F92EE;'>#基金#</a>坚持学习谢谢分享谢谢, objectTitle=基金, objectType=topic, longId=42186, objectId=null, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=null, replyNumber=0, likeNumber=75, createdTime=2023-05-25, rootId=0, userName=齐广西, userId=3d162090300, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2138469, encodeId=caef2138469a0, content=<a href='/topic/show?id=c030421865b' target=_blank style='color:#2F92EE;'>#基金#</a>坚持学习打卡学习了学习了谢谢, objectTitle=基金, objectType=topic, longId=42186, objectId=null, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=null, replyNumber=0, likeNumber=110, createdTime=2023-05-22, rootId=0, userName=齐广西, userId=3d162090300, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2136451, encodeId=15c1213645188, content=<a href='/topic/show?id=c030421865b' target=_blank style='color:#2F92EE;'>#基金#</a>学习打卡, objectTitle=基金, objectType=topic, longId=42186, objectId=null, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=null, replyNumber=0, likeNumber=109, createdTime=2023-05-17, rootId=0, userName=498997979, userId=edcf4883751, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2133828, encodeId=7d4d21338281f, content=<a href='/topic/show?id=c030421865b' target=_blank style='color:#2F92EE;'>#基金#</a>学习, objectTitle=基金, objectType=topic, longId=42186, objectId=null, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=null, replyNumber=0, likeNumber=70, createdTime=2023-05-15, rootId=0, userName=1581f8c42cm, userId=41e02111625, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2133757, encodeId=d73f2133e573d, content=<a href='/topic/show?id=c030421865b' target=_blank style='color:#2F92EE;'>#基金#</a>学习，共同进步, objectTitle=基金, objectType=topic, longId=42186, objectId=null, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=null, replyNumber=0, likeNumber=71, createdTime=2023-05-14, rootId=0, userName=146480bem82暂无昵称, userId=05155126416, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2131518, encodeId=74be2131518ef, content=<a href='/topic/show?id=c030421865b' target=_blank style='color:#2F92EE;'>#基金#</a>学习了, objectTitle=基金, objectType=topic, longId=42186, objectId=null, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=null, replyNumber=0, likeNumber=79, createdTime=2023-05-11, rootId=0, userName=ms5000000069254713, userId=c5a25410119, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2131509, encodeId=b6c62131509f2, content=<a href='/topic/show?id=049b86109ff' target=_blank style='color:#2F92EE;'>#自噬#</a><a href='/topic/show?id=c030421865b' target=_blank style='color:#2F92EE;'><a href='/topic/show?id=c030421865b' target=_blank style='color:#2F92EE;'>#基金#</a></a>这是日本的<a href='/topic/show?id=c030421865b' target=_blank style='color:#2F92EE;'><a href='/topic/show?id=c030421865b' target=_blank style='color:#2F92EE;'>#基金#</a></a>项目，通过查询国际的基金项目，也可以为我们<a href='/topic/show?id=cebd410388c' target=_blank style='color:#2F92EE;'>#国自然基金#</a>申请提供参考！这是极为难得的资源！千万不能错过, objectTitle=マルチモードオートファジー：多彩な経路と選択性が織り成す自己分解系の理解<br />Multimode autophagy, objectType=nsfc, longId=1319010, objectId=b71f13190101f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/sci/nsfc_show.do?id=b71f13190101f, replyNumber=0, likeNumber=94, createdTime=2023-05-11, rootId=0, userName=侠胆医心, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=b71f13190101f, moduleTitle=マルチモードオートファジー：多彩な経路と選択性が織り成す自己分解系の理解<br />Multimode autophagy, moduleType=nsfc, hrefUrl=https://www.medsci.cn/sci/nsfc_show.do?id=b71f13190101f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2131510, encodeId=3c75213151044, content=<a href='/topic/show?id=cd521538e99' target=_blank style='color:#2F92EE;'>#Rett综合征#</a><a href='/topic/show?id=1e5d1145e8c' target=_blank style='color:#2F92EE;'>#MeCP2#</a>这是日本的<a href='/topic/show?id=c030421865b' target=_blank style='color:#2F92EE;'>#基金#</a>，大家可以研究国外的基金情况，为申请<a href='/topic/show?id=cebd410388c' target=_blank style='color:#2F92EE;'>#国自然基金#</a>的申请提供参考, objectTitle=MECP2の発現制御によるRett症候群/MECP2重複症候群の遺伝子治療開発<br />Development of gene therapy for Rett syndrome / MECP2 duplication syndrome by regulating the expression of MECP2, objectType=nsfc, longId=1229729, objectId=7b051229e2963, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/sci/nsfc_show.do?id=7b051229e2963, replyNumber=0, likeNumber=118, createdTime=2023-05-11, rootId=0, userName=侠胆医心, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=7b051229e2963, moduleTitle=MECP2の発現制御によるRett症候群/MECP2重複症候群の遺伝子治療開発<br />Development of gene therapy for Rett syndrome / MECP2 duplication syndrome by regulating the expression of MECP2, moduleType=nsfc, hrefUrl=https://www.medsci.cn/sci/nsfc_show.do?id=7b051229e2963)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

基金

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#基金# #乳腺癌#

乳腺癌，美国在研的760项基金项目简述（2024）

2024-09-09发表于上海

ms1000000687639315 (审核中...)

前往app查看评论内容

#基金# 平台太高，水太深

2023-12-17发表于江苏省

ms2000000396662378 (审核中...)

前往app查看评论内容

全文收起 #基金# 中科院植物园全国招募药用植物学中药学相关专业联合培养研究生（长期有效），联合培养单位位于世界风景名胜区庐山，目前一园四区格局，分别在南昌、九江、庐山风景区、庐山市设实验室和办公区，并在江西各地设有多个研究基地。因中草药研究项目需要，现长期向全国高校招聘以下专业联合培养硕士、博士研究生（中药学及相关专业，植物学、生物技术、农学、生物信息学、生态学等）。导师将协助与所在高校相关合作手续，研究开展期间发放有竞争力的生活补助并提供食宿。有意者可联系 chengcs@lsbg.cn

2023-12-06发表于澳门

ms5000000069254713 (审核中...)

前往app查看评论内容

#基金#学习了

2023-06-24

146480bem82暂无昵称 (审核中...)

前往app查看评论内容

#基金#基金不是一个人想弄就弄得

2023-06-11

雪莲药师 (审核中...)

前往app查看评论内容

#基金#学习打卡谢谢分享谢谢老师分享

2023-06-11

移动雪莲 (审核中...)

前往app查看评论内容

#基金#学习打卡谢谢分享谢谢老师分享

2023-06-11

ms300 (审核中...)

前往app查看评论内容

#基金#学习打卡

2023-06-12

移动雪莲 (审核中...)

前往app查看评论内容

#基金#坚持学习谢谢分享谢谢

2023-06-10

移动雪莲 (审核中...)

前往app查看评论内容

#基金#非常好谢谢分享学习了谢谢

2023-06-09

齐广西 (审核中...)

前往app查看评论内容

#基金#有没有科研基金基层啊

2023-06-08

移动雪莲 (审核中...)

前往app查看评论内容

#基金#坚持学习谢谢分享谢谢

2023-05-25

齐广西 (审核中...)

前往app查看评论内容

#基金#坚持学习谢谢分享谢谢

2023-05-25

齐广西 (审核中...)

前往app查看评论内容

#基金#坚持学习打卡学习了学习了谢谢

2023-05-22

498997979 (审核中...)

前往app查看评论内容

#基金#学习打卡

2023-05-17

1581f8c42cm (审核中...)

前往app查看评论内容

#基金#学习

2023-05-15

146480bem82暂无昵称 (审核中...)

前往app查看评论内容

#基金#学习，共同进步

2023-05-14

ms5000000069254713 (审核中...)

前往app查看评论内容

#基金#学习了

2023-05-11

侠胆医心 (审核中...)

前往app查看评论内容

#自噬##基金#这是日本的 #基金#项目，通过查询国际的基金项目，也可以为我们#国自然基金#申请提供参考！这是极为难得的资源！千万不能错过

マルチモードオートファジー：多彩な経路と選択性が織り成す自己分解系の理解<br />Multimode autophagy

2023-05-11发表于上海

侠胆医心 (审核中...)

前往app查看评论内容

#Rett综合征##MeCP2#这是日本的#基金#，大家可以研究国外的基金情况，为申请#国自然基金#的申请提供参考

MECP2の発現制御によるRett症候群/MECP2重複症候群の遺伝子治療開発<br />Development of gene therapy for Rett syndrome / MECP2 duplication syndrome by regulating the expression of MECP2

2023-05-11发表于上海

科室
- - 订阅+
  - 更多科室
工具
服务